introduction orthostatic hypotension defined decrease systolic and/or diastolic blood pressure 20/10 mmhg upon standing common condition population whereas specific reversible clinical cause condition excessive blood pressure lowering therapy dehydration population often indicates degree cardiovascular autonomic dysfunction strongly associated cardiovascular disease cvd often correlate marker poor cardio-metabolic health previous study shown even subtle change indicating cardiovascular autonomic dysfunction early sign cardio-metabolic disease predict cardiovascular mortality metabolic syndrome defined visceral obesity dyslipidemia hyperglycemia hypertension major health concern affecting steadily increasing part global population affected known high risk cardiovascular event stroke myocardial infarction account today approximately one third death globally unhealthy diet low level physical activity two major risk factor modified recent decade development method identify measure quantity metabolite accelerated metabolome seen footprint overall health status composition may potentially yield valuable information multiple disease affected genetics diet physical activity microbiome inflammation/stress metabolic condition hormonal homeostasis drug treatment special attention paid composition metabolome order investigate certain single metabolite composition metabolome linked cardio-metabolic disease way could make suitable marker risk assessment recent year bacterial endotoxin like lipopolysaccharides degradants component red meat trimethylamine oxide tmao several short chain fatty acid scfa branched-chain amino acid bcaa aromatic amino acid aaa well bile acid found associated different outcome cardio-metabolic disease besides change lifestyle diet fecal microbiota transplantation probiotic prebiotic antibiotic treatment well small molecule antimicrobial enzyme therapeutic proposed intervention target gut microbiota thereby imbalance metabolome whether component metabolome associated marker autonomic dysfunction impaired orthostatic blood pressure response unknown orthostatic hypotension closely associated cardiovascular risk factor metabolic syndrome especially elderly population therefore hypothesized metabolite example sphingolipids associated hypertension diabetes cardiovascular disease may also associated cardiovascular autonomic dysfunction term maladaptive orthostatic blood pressure response explorative study examined association orthostatic blood pressure response untargeted plasma metabolite random sample middle-aged population method study population swedish cardiopulmonary bioimage study scapis collaborative study six swedish university university hospital gothenburg malmö linköping stockholm uppsala umeå total 30,154 subject general population age range 50–64 year invited letter participate period 2013–2018 total men woman included malmö site corresponded participation rate comprehensive examination carried three different day one week apart participant total individual information plasma metabolite measure recorded orthostatic blood pressure response visit excluding subject missing value orthostatic blood pressure reaction information covariates e.g. bmi diabetes smoking status anti-hypertensive medicine resting heart rate total subject included fully adjusted analysis fig figure flowchart study population full size image written informed consent obtained participant study scapis project approved ethical review board umeå university ethical review board lund 2016/1031 method performed accordance relevant guideline regulation analysis plasma metabolite baseline examination scapis overnight fasting blood sample drawn morning stored -80 time metabolomics analysis study non-targeted metabolomics metabolon inc. durham north carolina usa performed plasma sample sample prepared automated microlab star® system hamilton company reno nevada usa purpose quality control several internal standard used prior extraction process protein precipitated methanol vigorously shaken min followed centrifugation glen mill genogrinder remove protein dissociate small molecule bound trapped precipitated protein matrix recover chemically diverse metabolite resulting extract divided five fraction one analysis reverse phase performance liquid chromatography-tandem mass spectroscopy uplc-ms/ms method negative ion mode electrospray ionization esi one analysis hilic/uplc-ms/ms negative ion mode esi two analysis two separate rp/uplc-ms/ms method positive ion mode esi one sample reserved backup raw data metabolite extracted peak-identified quality control-processed metabolon hardware software described previously compound annotated matching library purified standard metabolite recurrent unknown entity library based authenticated standard contains retention time/index mass charge ratio m/z chromatographic data missing value metabolite imputed minimum value across batch addition metabolite assigned broad biochemical class well specific biochemical class metabolite sub-pathway analysis metabolite classified drug xenobiotics converted present absent metabolite level normalized natural logarithm value given arbitrary unit annotated metabolite call rate non-drug related xenobiotics included analysis resulting metabolite included non-drug related xenobiotics orthostatic blood pressure reaction measurement orthostatic blood pressure reaction calculated subtracting blood pressure min standing blood pressure measured min resting supine position measured millimeter quicksilver mmhg orthostatic hypotension defined decrease systolic and/or diastolic blood pressure greater 20/10 mmhg upon standing blood pressure measured twice supine position arm automatic device minute rest omron m10‐it omron healthcare co. kyoto japan average two blood pressure recording arm higher mean blood pressure included analysis recording supine position arm supported heart level risk factor examination baseline information collected examination body weight standing height meter measured without shoe body mass index bmi calculated weight kilogram divided square height meter kg/m smoking status obtained questionnaire ascertained smoker non-smokers diabetes defined previously known diabetes self-reported getting diagnosed examination elevated fasting plasma glucose sample antihypertensive treatment defined according answer questionnaire taking medicine high blood pressure last week detailed information method used malmö cohort scapis found elsewhere statistical analysis continuous variable presented mean standard deviation categorical variable shown number percentage association metabolite independent variable tested one one orthostatic systolic blood pressure response dependent variable determined using multiple linear regression analysis multivariate model adjusted potential confounders follows model adjusted age gender systolic blood pressure model additionally adjusted bmi diabetes smoking status anti-hypertensive drug treatment beta coefficient confidence interval reported considering number metabolite decided use bonferroni correction minimize chance false-positive finding bonferroni corrected value maximum 6.11 0.05/818 considered significant analysis metabolite model selected metabolite significantly associated orthostatic systolic blood pressure response model examine relationship additional adjustment model bonferroni-corrected value 2.273 0.05/22 considered significant model addition also explored association metabolite manifest using logistic regression analysis two model conducted result reported value 6.11 regarded statistically significant analysis performed using ibm spss statistic v.27 www.spss.com studio version 1.3.1093 result characteristic study population characteristic study population presented table short 47.9 total participant men mean age year average study population slightly elevated bmi bmi kg/m diabetes mellitus prevalent 8.3 manifest orthostatic hypotension present recording i.e 1.5 systolic blood pressure normal average mmhg total 14.4 current smoker 20.3 reported antihypertensive drug treatment table characteristic study population full size table subject excluded fully adjusted analysis slightly higher prevalence higher resting blood pressure slightly likely diabetes smoker supplementary table orthostatic systolic blood pressure response plasma metabolite significant result association metabolite orthostatic systolic blood pressure response depicted table fig adjusted age gender systolic blood pressure model found six amino acid five cofactor vitamin carbohydrate nine lipid two xenobiotics significantly associated orthostatic blood pressure response bonferroni corrected value 6.11 table metabolite associated orthostatic blood pressure response full size table table metabolite associated orthostatic blood pressure response fully adjusted model full size table figure forest plot significant association metabolite systolic orthostatic blood pressure response full adjustment model adjusted age gender systolic blood pressure diabetes anti-hypertensive medication bmi smoking full size image additional adjustment bmi diabetes smoking antihypertensive treatment model table found significant association six lipid three amino acid one xenobiotic one uncharacterized molecule orthostatic systolic blood pressure response bonferroni corrected value 2.273 metabolite negative beta coefficient relation systolic blood pressure decrease see table fig i.e higher level metabolite associated pronounced systolic blood pressure decrease significant association found level metabolite manifest orthostatic hypotension data shown respective molecule biological pathway metabolite included listed detail table discussion overall finding performed exploratory analysis possible association metabolite orthostatic blood pressure reaction general population found eleven metabolite associated systolic orthostatic blood pressure response adjusting multiple testing conventional cardiovascular risk factor metabolite significantly associated manifest bonferroni adjustment population looking specifically relationship metabolite half lipid associated systolic orthostatic blood pressure response adjusted age gender systolic blood pressure eleven metabolite likewise predominantly metabolite lipid pathway remained significantly associated adjusting also diabetes bmi smoking anti-hypertensive treatment lipid xenobiotics associated orthostatic blood pressure response mainly showed negative beta coefficient relation orthostatic blood pressure response i.e higher level associated pronounced systolic blood pressure decrease whereas vitamin cofactor amino acid showed positive beta coefficient relation orthostatic blood pressure response i.e higher level associated pronounced systolic blood pressure decrease standing table fig eleven metabolite displayed significant association orthostatic blood pressure response adjusting cvd risk factor diverse however included six lipid involved mainly dihydro-sphingomyelins sphingosines phosphatidylcholine fatty acid metabolism acyl carnitine polyunsaturated pathway furthermore amino acid play role creatine glutamate methionine cysteine sam taurine metabolism pathway food/plant based component gucuronide piperine metabolite well glutamine degradant respectively table lipid metabolite relation orthostatic blood pressure reaction six lipid metabolite associated systolic orthostatic blood pressure response mainly sphingolipids metabolite found cell membrane behenoyl dihydro-sphingomyelin dhsm sphingolipid found 5–10 cell play role membrane-related biological process shown associated high bmi nonalcoholic fatty liver disease previous study sphingomyelin found mainly membranous myelin sheath suggested insulator nerve fiber discovered play role cell signaling pathway including apoptosis excessive sphingomyelin previously shown associated insulin resistance sphingosine sphingadiene backbone sphingolipids derivative important second messenger involved function cell growth differentiation apoptosis negative association sphingolipids systolic orthostatic blood pressure decrease may possibly explained previously shown association high bmi nonalcoholic fatty liver disease insulin resistance addition recent study shown sphingolipid plasma s1p sphingosine-1-phosphate link hypertension biomarkers inflammation cardiovascular disease s1p shown released circulating cell leukocyte erythrocyte blood platelet facilitated among others influence inflammatory mediator tnf-alpha study s1p wasn´t shown associate orthostatic blood pressure response adjusting age gender supine systolic blood pressure role sphingolipids cell process sphingomyelin role nerve insulator could hand regarded protective feature orthostatic hypotension dihomo-linoleoylcarnitine another metabolite associated systolic orthostatic blood pressure response previous finding dihomo-linoleic acid obesity metabolic health human mixed rodent study beneficial effect dietary linoleic acid administration found insulin resistance glucose tolerance long-chain acyl fatty acid derivative accumulate cytosol serum patient suffering mitochondrial carnitine palmitoyltransferase deficiency common inherited disorder lipid metabolism adult carnitine play critical role energy production transport long-chain fatty acid mitochondrion oxidized produce energy also transport toxic compound generated cellular organelle prevent accumulation given key function carnitine concentrated tissue like skeletal cardiac muscle utilize fatty acid dietary fuel found one previous study metabolic change preceding cardiac dysfunction showed association linoleoylcarnitine hypertension hypertension-induced left ventricular hypertrophy rodent study dihomo-linoleoyl carnitine found positive association systolic orthostatic blood pressure decrease 1-myristoyl-2-arachidonoyl-gpc metabolite phosphatidylcholine metabolism much known molecule whereas three metabolite pathway choline trimethylamine n-oxide tmao betaine respectively previously showed predict risk cvd phospholipid synthesis shown vital cell survival normal development maintenance health alteration phospholipid level previously shown associated lipid profile obesity insulin resistance hypertension well hypertension-induced left ventricular hypertrophy rodent found 1-myristol-2-arachidonoyl-gpc inversely associated systolic orthostatic blood pressure decrease amino acid metabolite relation orthostatic blood pressure reaction study three amino acid one derivative showed association systolic orthostatic blood pressure response creatine amino acid abundant muscle heart brain primary role bind inorganic phosphate cell form phosphocreatine thereby serve high-energy phosphate source energy resynthesize adenosine triphosphate atp degraded adenosine diphosphate adp source energy fuel cellular metabolism increase cellular energy availability among consumed bodybuilder muscle gain also shown neuroprotective thought anti-inflammatory immunomodulating effect study creatine negative association systolic orthostatic blood pressure response cysteine-s-sulfate abnormal metabolite discovered urine blood patient cysteine oxidase deficiency rare disorder sulfur amino acid metabolism associated brain damage mental retardation found inversely associated systolic orthostatic blood pressure decrease glutamine abundant versatile amino acid body health disease rate glutamine consumption immune cell similar greater glucose instance vitro vivo study determined glutamine essential nutrient lymphocyte proliferation cytokine production macrophage phagocytic plus secretory activity neutrophil bacterial killing glutamine release circulation availability mainly controlled key metabolic organ gut liver skeletal muscle catabolic/hypercatabolic situation glutamine become essential metabolic function symptom glutamine deficiency include increased susceptibility infection bowel change diarrhea ulcer weight loss side effect high level vegetative symptom skin rash muscle joint pain swelling hand foot found glutamine glutamine degradant positive association systolic orthostatic blood pressure decrease metabolite relation orthostatic blood pressure reaction metabolite glucuronidation piperine pathway black pepper constituent recently shown antioxidant anti-inflammatory antidiabetic anti-mutagenic tumor-inhibiting drug metabolism inhibiting antidiarrheal property human blood pressure lowering effect previously reported animal experiment found glucuronide piperine metabolite negative association systolic orthostatic blood pressure response limitation exploratory study meaning needed apply correction multiple testing chose bonferroni approach may conservative however lowering risk type error exploratory nature study also mean result confirmed independent sample epidemiological clinical impact result yet determined still find result valuable base study finding general population age group 50–64 year may generalized age group regarding metabolome cardio-metabolic health would interesting future study compare metabolome young healthy age group middle aged old age group cardio-metabolic disease develops progress throughout lifetime may become manifest age-group current study least subclinical disease increased prevalence orthostatic hypotension seen 6th decade rising exponentially last decade life analyzed possible association orthostatic blood pressure response marker suggested autonomic dysfunction metabolite cover many pathway possible examined every metabolite test pattern difference cluster metabolite may discussed whether subtle change orthostatic blood pressure adaptation seen generally healthy population reflects overt autonomic dysfunction however postural change blood pressure one five ewing test used assessing autonomic function several decade impaired orthostatic blood pressure reaction well deep breathing test previously shown associated coronary artery calcium deposit scapis cross-sectional design limit interpretation result comment cause effect single metabolite orthostatic blood pressure response solely association exists however known autonomic dysfunction case consequence cardio-metabolic disease methodological limitation orthostatic blood pressure response measured min standing additional measurement record possible delayed abnormal orthostatic blood pressure response low prevalence manifest orthostatic hypotension concordance prevalence found earlier study nevertheless low prevalence limitation hard predict reliability single visit evaluation orthostatic hypotension known possibly affected acute transient condition like dehydration hypoglycemia fatigue low blood count reliability single orthostatic blood pressure recording assessed future study also mentioned precise measurement orthostatic blood pressure reaction including detection transient orthostatic hypotension achieved tilt-test prolonged continuous blood pressure heart rate monitoring min tilting another limitation exploratory study didn´t adjust kidney liver function condition could possibly influence absorption excretion accumulation half-life metabolite thereby level measured concentration hand managed include vast amount metabolite analysis real effect metabolite found associate orthostatic blood pressure response addressed thoroughly future study finally since assessed linear model study rule metabolite could non-linearly related orthostatic blood pressure reaction conclusion exploratory study found metabolite nine lipid associated orthostatic blood pressure response interest eleven metabolite including six lipid four amino acid one plant derivative associated orthostatic blood pressure response additional adjustment traditional metabolic cardiovascular risk factor whereas clinical importance finding currently limited suggest eleven metabolite pathway investigated order enhance understanding role metabolome association cardiovascular disease autonomic dysfunction perspective impaired orthostatic blood pressure response common phenomenon increase age even though condition may often asymptomatic even slightly impaired blood pressure response standing may reflect underlying cardiovascular autonomic dysfunction abnormality strongly associated cardiovascular risk factor incident cardiovascular disease metabolome believed harbor enormous pool novel valuable information cardiovascular disease study however investigated human metabolome relation autonomic dysfunction study identified eleven metabolite associated impaired systolic orthostatic blood pressure reaction middle-aged population-based cohort eleven metabolite seem involved diverse pathway including metabolism neuroprotection inflammation and/or immunomodulation whereas based early exploratory study think current result may still guide future research human metabolome relation cardiovascular autonomic dysfunction ultimately study may reveal new pathway could targeted treatment novelty relevance new study reveals eleven diverse metabolite independently associated impaired orthostatic blood pressure reaction relevant impaired orthostatic blood pressure reaction marker subtle cardiovascular autonomic dysfunction associated cardiovascular risk point eleven specific metabolite may involved association clinical pathological implication result may guide future research human metabolome relation cardiovascular autonomic dysfunction ultimately study may reveal new pathway could targeted prevention treatment cardiovascular disease